271 related articles for article (PubMed ID: 17616652)
1. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential.
Stauber RH; Mann W; Knauer SK
Cancer Res; 2007 Jul; 67(13):5999-6002. PubMed ID: 17616652
[TBL] [Abstract][Full Text] [Related]
2. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin.
Rodríguez JA; Span SW; Ferreira CG; Kruyt FA; Giaccone G
Exp Cell Res; 2002 Apr; 275(1):44-53. PubMed ID: 11925104
[TBL] [Abstract][Full Text] [Related]
3. Nuclear export is essential for the tumor-promoting activity of survivin.
Knauer SK; Krämer OH; Knösel T; Engels K; Rödel F; Kovács AF; Dietmaier W; Klein-Hitpass L; Habtemichael N; Schweitzer A; Brieger J; Rödel C; Mann W; Petersen I; Heinzel T; Stauber RH
FASEB J; 2007 Jan; 21(1):207-16. PubMed ID: 17099069
[TBL] [Abstract][Full Text] [Related]
4. Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential.
Lippert BM; Knauer SK; Fetz V; Mann W; Stauber RH
Int J Cancer; 2007 Sep; 121(6):1169-74. PubMed ID: 17617794
[TBL] [Abstract][Full Text] [Related]
5. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
[TBL] [Abstract][Full Text] [Related]
6. Cloning and functional characterization of the guinea pig apoptosis inhibitor protein Survivin.
Habtemichael N; Wünsch D; Bier C; Tillmann S; Unruhe B; Frauenknecht K; Heinrich UR; Mann WJ; Stauber RH; Knauer SK
Gene; 2010 Dec; 469(1-2):9-17. PubMed ID: 20727954
[TBL] [Abstract][Full Text] [Related]
7. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax.
Temme A; Rodriguez JA; Hendruschk S; Günes S; Weigle B; Schäkel K; Schmitz M; Bachmann M; Schackert G; Rieber EP
Cancer Lett; 2007 Jun; 250(2):177-93. PubMed ID: 17084966
[TBL] [Abstract][Full Text] [Related]
8. Survivin's dual role: an export's view.
Knauer SK; Mann W; Stauber RH
Cell Cycle; 2007 Mar; 6(5):518-21. PubMed ID: 17361097
[TBL] [Abstract][Full Text] [Related]
9. Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy.
Suzuki Y; Oka K; Yoshida D; Shirai K; Ohno T; Kato S; Tsujii H; Nakano T
Gynecol Oncol; 2007 Mar; 104(3):642-6. PubMed ID: 17141299
[TBL] [Abstract][Full Text] [Related]
10. Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining.
Skagias L; Politi E; Karameris A; Sambaziotis D; Archondakis A; Ntinis A; Moreas I; Vasou O; Koutselini H; Patsouris E
Anticancer Res; 2009 Oct; 29(10):4163-7. PubMed ID: 19846967
[TBL] [Abstract][Full Text] [Related]
11. Leucine-rich nuclear-export signals: born to be weak.
Kutay U; Güttinger S
Trends Cell Biol; 2005 Mar; 15(3):121-4. PubMed ID: 15752974
[TBL] [Abstract][Full Text] [Related]
12. Targeting survivin in cancer therapy: fulfilled promises and open questions.
Pennati M; Folini M; Zaffaroni N
Carcinogenesis; 2007 Jun; 28(6):1133-9. PubMed ID: 17341657
[TBL] [Abstract][Full Text] [Related]
13. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F
Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333
[TBL] [Abstract][Full Text] [Related]
14. Expression of survivin and correlation with PCNA in osteosarcoma.
Wang W; Luo H; Wang A
J Surg Oncol; 2006 Jun; 93(7):578-84. PubMed ID: 16705726
[TBL] [Abstract][Full Text] [Related]
15. Survivin study: what is the next wave?
Li F
J Cell Physiol; 2003 Oct; 197(1):8-29. PubMed ID: 12942537
[TBL] [Abstract][Full Text] [Related]
16. Survivin: an inhibitor of apoptosis in pediatric cancer.
Fangusaro JR; Caldas H; Jiang Y; Altura RA
Pediatr Blood Cancer; 2006 Jul; 47(1):4-13. PubMed ID: 16534789
[TBL] [Abstract][Full Text] [Related]
17. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.
Engels K; Knauer SK; Metzler D; Simf C; Struschka O; Bier C; Mann W; Kovács AF; Stauber RH
J Pathol; 2007 Apr; 211(5):532-540. PubMed ID: 17334981
[TBL] [Abstract][Full Text] [Related]
18. Nuclear or cytoplasmic expression of survivin: what is the significance?
Li F; Yang J; Ramnath N; Javle MM; Tan D
Int J Cancer; 2005 Apr; 114(4):509-12. PubMed ID: 15578717
[TBL] [Abstract][Full Text] [Related]
19. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.
Mita AC; Mita MM; Nawrocki ST; Giles FJ
Clin Cancer Res; 2008 Aug; 14(16):5000-5. PubMed ID: 18698017
[TBL] [Abstract][Full Text] [Related]
20. Cancer cells survive with survivin.
Yamamoto H; Ngan CY; Monden M
Cancer Sci; 2008 Sep; 99(9):1709-14. PubMed ID: 18537980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
